Stem Cell Differentiation: Long Term Follow Up
干细胞分化:长期随访
基本信息
- 批准号:6527985
- 负责人:
- 金额:$ 25.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-30 至 2005-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant):
The proposed existence of adult, marrow derived stem cells that have retained
the potential to generate muscle, liver, neurons, etc., is conceptually
appealing. However the current data in support of this concept are more
intriguing than compelling. To contribute to the resolution of this
uncertainty we propose to investigate the contribution of donor marrow stem
cells to skin, gut epithelium, liver, muscle, and marrow stroma. We
hypothesize that if "plastic stem cells" originate or reside in marrow they
will, with time and/or challenge, contribute to nonhematopoietic tissue
regeneration. To test this hypothesis we propose to analyze tissue from
patients who are long term survivors of sex mismatched allogeneic marrow
transplantation. Currently there are more than 2,300 patients from 1 to 25
years post transplant, who are being actively followed for late complications
by the Long Term Follow UP (LTFU) program of the Fred Hutchinson Cancer
Research Center. These complications affect all organ systems including skin,
eyes, GI tract, liver, lungs, muscles, connective tissue, bladder, kidneys,
and central nervous system. Through the efforts of the LTFU office an aliquot
of tissue biopsies obtained for diagnostic purposes will be made available for
studies proposed here. Tissue samples from these patients will be evaluated
in two ways: first, by standard fluorescence in situ hybridization (FISH) for
detection of sex chromatin in histological sections; second, by ex vivo
expansion of defined cell populations followed by FISH as well as polymerase
chain reaction (pcr) amplification of donor versus host DNA. These strategies
should improve the signal to noise ratio and make the detection of donor
derived cells more reliable. The information gained should help define
whether, and under what circumstances, marrow derived stem cells contribute to
other tissues following allogeneic transplantation.
描述(由申请人提供):
建议存在的成人,骨髓来源的干细胞,保留了
产生肌肉、肝脏、神经元等的潜力,在概念上
很吸引人。然而,目前支持这一概念的数据更多
有趣而不是引人注目。为解决这一问题做出贡献
不确定性,我们建议研究供体骨髓干细胞的贡献
细胞到皮肤、肠上皮、肝脏、肌肉和骨髓基质。我们
假设如果“可塑性干细胞”起源于或存在于骨髓中,
随着时间的推移和/或挑战,
再生为了验证这一假设,我们建议分析组织,
性别不匹配的同种异体骨髓长期存活的患者
移植目前有2,300多名患者从1岁到25岁
移植后10年,正在积极随访晚期并发症
由Fred哈钦森癌症中心的长期随访(LTFU)计划
研究中心这些并发症影响所有器官系统,包括皮肤,
眼睛、胃肠道、肝脏、肺、肌肉、结缔组织、膀胱、肾脏,
和中枢神经系统。通过长期信托基金办公室的努力,
为诊断目的获得的组织活检将提供给
在此提出的研究。将对这些患者的组织样本进行评价
方法有两种:一是通过标准荧光原位杂交(FISH)
检测组织切片中的性染色质;第二,通过离体
扩增确定的细胞群,然后进行FISH以及聚合酶
供体与宿主DNA的链式反应(PCR)扩增。这些策略
应提高信噪比,使供体的检测
衍生细胞更可靠。获得的信息应有助于确定
骨髓来源的干细胞是否以及在什么情况下有助于
同种异体移植后的其他组织。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BEVERLY J. TOROK-STORB其他文献
BEVERLY J. TOROK-STORB的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BEVERLY J. TOROK-STORB', 18)}}的其他基金
Core Center for Stem Cell and Transplantation Biology
干细胞和移植生物学核心中心
- 批准号:
10201079 - 财政年份:2015
- 资助金额:
$ 25.95万 - 项目类别:
Core Center for Stem Cell and Transplantation Biology
干细胞和移植生物学核心中心
- 批准号:
9750688 - 财政年份:2015
- 资助金额:
$ 25.95万 - 项目类别:
Core Center for Stem Cell and Transplantation Biology
干细胞和移植生物学核心中心
- 批准号:
9329844 - 财政年份:2015
- 资助金额:
$ 25.95万 - 项目类别:
Core Center for Stem Cell and Transplantation Biology
干细胞和移植生物学核心中心
- 批准号:
9987199 - 财政年份:2015
- 资助金额:
$ 25.95万 - 项目类别:
相似海外基金
Prevention of age-related hearing loss using bone marrow transplantation
利用骨髓移植预防与年龄相关的听力损失
- 批准号:
23K08999 - 财政年份:2023
- 资助金额:
$ 25.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A Novel Bone Marrow Transplantation Approach for Sickle Cell Disease Using Targeted Marrow Irradiation
使用靶向骨髓照射治疗镰状细胞病的新型骨髓移植方法
- 批准号:
10737358 - 财政年份:2023
- 资助金额:
$ 25.95万 - 项目类别:
Tuning tyrosine kinase signalling to improve haematopoietic stem cell expansion and bone marrow transplantation
调节酪氨酸激酶信号传导以改善造血干细胞扩增和骨髓移植
- 批准号:
2889841 - 财政年份:2023
- 资助金额:
$ 25.95万 - 项目类别:
Studentship
A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
一项针对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者进行非亲缘供体骨髓移植与免疫抑制治疗比较的 III 期随机试验
- 批准号:
10722602 - 财政年份:2022
- 资助金额:
$ 25.95万 - 项目类别:
A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
一项针对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者进行非亲缘供体骨髓移植与免疫抑制治疗比较的 III 期随机试验
- 批准号:
10368246 - 财政年份:2022
- 资助金额:
$ 25.95万 - 项目类别:
1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
1/2A III 期随机试验,比较无关供体骨髓移植与免疫抑制治疗对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者的影响
- 批准号:
10600143 - 财政年份:2022
- 资助金额:
$ 25.95万 - 项目类别:
1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
1/2A III 期随机试验,比较无关供体骨髓移植与免疫抑制治疗对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者的影响
- 批准号:
10370775 - 财政年份:2022
- 资助金额:
$ 25.95万 - 项目类别:
The mycobiota, bone marrow transplantation, and clinical outcomes
真菌群、骨髓移植和临床结果
- 批准号:
10415200 - 财政年份:2021
- 资助金额:
$ 25.95万 - 项目类别:
The mycobiota, bone marrow transplantation, and clinical outcomes
真菌群、骨髓移植和临床结果
- 批准号:
10303678 - 财政年份:2021
- 资助金额:
$ 25.95万 - 项目类别: